20 Old Brompton Road – South Kensington
Back to BlogCancer

Understanding Bowel Cancer Risk: Why Early Screening Matters

PBTT

Private Blood Tests Team

Clinical Team

20 Mar 202614 min read

What Is Bowel Cancer Screening and Why Does It Matter?

Bowel cancer screening refers to a range of tests designed to detect early indicators of colorectal abnormalities before symptoms become apparent. It typically involves stool-based tests that identify hidden blood, as well as blood tests that assess relevant biomarkers. Understanding bowel cancer risk is an essential part of proactive health management, particularly for individuals over 50 or those with a family history of the condition.

Bowel cancer is the fourth most common cancer in the UK, with approximately 43,000 new cases diagnosed each year according to Cancer Research UK. Yet when identified early — at stage one — survival rates can exceed 90%. This is precisely why early screening matters: it provides an opportunity to identify potential concerns at a point when outcomes may be significantly more favourable.

For residents across London seeking convenient, confidential health assessments, private blood testing can offer a valuable complement to NHS screening pathways. At Private Blood Tests London, our nurse-led clinic provides a range of health screening blood tests that may help individuals take a more informed approach to their wellbeing.

How Common Is Bowel Cancer in the UK?

Bowel cancer — also referred to as colorectal cancer — remains one of the most prevalent cancers across the United Kingdom. To place this in context:

  • Approximately 43,000 people are diagnosed annually in the UK
  • It accounts for roughly 12% of all new cancer cases
  • The condition is more common in individuals aged 50 and over
  • Around 54% of bowel cancer cases in the UK are considered preventable (Cancer Research UK)
  • The NHS Bowel Cancer Screening Programme currently invites adults aged 54 to 74 in England
  • Practical Insight: Being aware of your personal risk factors — including age, family history, and lifestyle — can help you decide whether private screening may be a useful step alongside routine NHS checks.

    Who Should Consider Bowel Cancer Screening?

    While the NHS offers bowel cancer screening to eligible age groups, there are several circumstances in which individuals may wish to consider additional or earlier screening through a private pathway.

    You May Wish to Consider Screening If You:

  • Are aged 40 or over with a family history of bowel cancer
  • Have noticed persistent changes in bowel habits lasting more than three weeks
  • Have experienced unexplained fatigue or weight loss
  • Have a personal history of inflammatory bowel conditions
  • Are between NHS screening intervals and wish to monitor key biomarkers
  • Simply wish to take a proactive approach to your health
  • It is important to note that screening blood tests do not diagnose bowel cancer. They may, however, highlight biomarker levels that could warrant further investigation with an appropriate healthcare professional. For a broader overview, our article on whether blood tests can detect cancer explores the role of different biomarkers in cancer risk screening.

    Key Biomarkers Relevant to Bowel Cancer Risk

    Blood tests used in bowel cancer risk assessment typically focus on several important biomarkers. Understanding what these markers measure can help you interpret your results more confidently.

    Full Blood Count (FBC)

    A full blood count measures various components of your blood, including haemoglobin and red blood cell levels. Iron deficiency anaemia — identified through low haemoglobin — can sometimes be associated with slow, undetected blood loss from the bowel. While anaemia has many possible causes, unexplained iron deficiency in certain age groups may prompt further clinical assessment.

    Ferritin and Iron Studies

    Ferritin reflects the body’s iron stores. Persistently low ferritin levels, particularly in men or post-menopausal women, can sometimes highlight the need for further investigation, as chronic occult blood loss from the gastrointestinal tract may be a contributing factor.

    C-Reactive Protein (CRP)

    CRP is a general marker of inflammation within the body. Elevated CRP levels can suggest an inflammatory process, though this marker is not specific to bowel conditions. It is often used alongside other biomarkers to build a broader clinical picture.

    Carcinoembryonic Antigen (CEA)

    CEA is a tumour marker that may be elevated in certain types of cancer, including colorectal cancer. However, raised CEA levels can also occur in non-cancerous conditions such as smoking, liver disease, or inflammatory bowel disease. CEA is not used as a standalone diagnostic tool but may provide useful supplementary information.

    Practical Insight: No single blood test can confirm or rule out bowel cancer. However, a combination of biomarker results can sometimes highlight patterns that suggest further clinical evaluation may be beneficial.

    NHS Bowel Cancer Screening vs Private Blood Testing

    Many individuals across London find it helpful to understand the differences between NHS screening and private blood testing options. The following comparison outlines some key distinctions:

    FeatureNHS Bowel Cancer ScreeningPrivate Blood Testing (London)
    EligibilityAges 54–74 (England)Any adult, any age
    Test TypeFIT (Faecal Immunochemical Test)Blood biomarker panels
    FrequencyEvery 2 yearsAs frequently as desired
    Waiting TimeSubject to NHS schedulingTypically available within days
    Results TurnaroundApproximately 2 weeksOften within 24–72 hours
    Appointment FlexibilityLimitedFlexible scheduling
    CostFreeFee applies
    LocationHome-based postal kitClinic-based in London
    Practical Insight: Private blood testing is not a replacement for NHS bowel screening. It may, however, offer a useful additional layer of health insight — especially for individuals who fall outside the current NHS age range or who wish to monitor their health more regularly.

    How Often Should You Screen for Bowel Cancer Risk?

    The frequency of screening depends on several individual factors, including age, family history, and personal health background.

  • General population (low risk): NHS screening every 2 years from age 54
  • Moderate risk (family history): Annual or biannual monitoring may be considered from age 40 onwards
  • Higher risk (personal or strong family history): More frequent monitoring in consultation with a healthcare professional
  • For blood-based biomarkers such as FBC, ferritin, and CRP, many individuals choose to have these checked annually as part of a broader health check. Our full blood count test is one of the most commonly requested panels for general health monitoring.

    Understanding Your Results

    When you receive your blood test results from our clinic, each biomarker will be presented with a reference range. Here is a general guide to interpretation:

  • Results within normal range: This is reassuring and may suggest that the markers assessed do not currently indicate a concern. Routine monitoring can help you track any changes over time.
  • Mildly abnormal results: Slight variations can sometimes occur due to diet, hydration, or temporary illness. Your results report will indicate whether follow-up is advisable.
  • Significantly abnormal results: If any biomarker falls well outside the expected range, it is important to seek medical advice from an appropriate healthcare professional for further assessment.
  • Practical Insight: Keeping a record of your blood test results over time can help you — and your healthcare provider — identify trends and make more informed decisions about your health.

    Private Bowel Cancer Risk Screening in London

    Living in London offers access to a wide range of private healthcare services, and Private Blood Tests London is proud to provide accessible, confidential blood testing from our centrally located nurse-led clinic. If you would like to understand more about what a full blood count can tell you, our guide to understanding your full blood count results provides a helpful breakdown.

    Our service is designed for individuals who:

  • Want timely access to blood testing without lengthy waiting times
  • Prefer flexible appointment scheduling to suit busy lifestyles
  • Wish to complement NHS screening with additional biomarker monitoring
  • Are seeking a straightforward, professional testing experience
  • You can explore our full range of available tests, including well man and well woman health screens, which include several of the biomarkers discussed in this article. For more on one of the key inflammatory markers mentioned above, see our article on C-reactive protein (CRP) blood tests explained.

    Frequently Asked Questions

    What is bowel cancer screening?

    Bowel cancer screening involves tests designed to detect early signs of colorectal abnormalities. In the UK, the NHS uses the FIT test, while private clinics may offer blood-based biomarker panels. Understanding bowel cancer risk through screening can support early identification, which is associated with more favourable outcomes.

    Can a blood test detect bowel cancer?

    A blood test alone cannot diagnose bowel cancer. However, certain biomarkers — such as haemoglobin, ferritin, CRP, and CEA — may highlight patterns that suggest further clinical evaluation could be beneficial. Blood testing is best used as a complementary tool alongside other screening methods.

    Who should consider early bowel cancer screening?

    Individuals with a family history of bowel cancer, those aged over 40, people experiencing persistent changes in bowel habits, and anyone wishing to take a proactive approach to their health may wish to consider early screening.

    How often should I have a bowel cancer risk blood test?

    For general health monitoring, annual blood testing that includes relevant biomarkers is a common approach. Those with specific risk factors may benefit from more frequent monitoring.

    What does a raised CEA level mean?

    Carcinoembryonic antigen (CEA) is a tumour marker that can be elevated in several conditions, including but not limited to colorectal cancer. Raised levels may also occur in smokers or individuals with liver or inflammatory bowel conditions. A raised CEA result should always be discussed with a healthcare professional.

    Is private bowel cancer screening available in London?

    Yes. Private blood testing clinics in London, including Private Blood Tests London, offer a range of blood tests that assess biomarkers relevant to bowel cancer risk. These tests are available to adults of any age and typically offer faster results and more flexible appointment scheduling.

    Taking a Proactive Approach to Your Health

    Understanding bowel cancer risk is an important part of maintaining long-term wellbeing. While no screening test offers certainty, regular monitoring of key biomarkers can provide valuable health insights and support early identification of potential concerns.

    If you are considering adding blood-based screening to your health routine, our nurse-led team at Private Blood Tests London is here to help.

    *This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Private Blood Tests London is a nurse-led screening service. We do not provide GP services, medical consultations, treatment, or prescriptions. If your results indicate areas of concern, please consult your GP or an appropriate healthcare professional.*

    *Written: 20 March 2026 | Review date: 20 March 2027*

    Ready to Book Your Test?

    Visit our CQC-registered clinic in South Kensington for professional blood testing services.